Spiral Therapeutics is a clinical-stage biotech developing therapies for inner ear disorders like hearing loss and balance conditions. It serves patients with conditions such as Meniere's disease and the clinicians treating them. Its MICS minimally-invasive cochlear platform delivers drugs directly to the cochlea while limiting systemic exposure.
acquisitions n=0
No cited completed company acquisition recorded.
traction n=0
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
valuations n=0
No cited valuation with an explicit basis is recorded.
revenue multiples n=0
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.